Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
kw-2449 | tyrosine-protein kinase abl1 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] |
0.58 | phase 1 | unknown |
kw-2449 | tyrosine-protein kinase abl1 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] |
0.58 | phase 1 | inhibitor |
kw-2449 | fibroblast growth factor receptor 1 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] |
0.14 | phase 1 | unknown |
kw-2449 | fms-like tyrosine kinase 3 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] |
0.4 | phase 1 | inhibitor |
kw-2449 | fms-like tyrosine kinase 3 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] |
0.4 | phase 1 | unknown |
click here to return to the previous page |